Fulgent Genetics Follow Verify

www.fulgentgenetics.com
Fulgent Genetics
Type	Public
Industry	Biotechnology
Founded	2011
Headquarters	Temple City, California 91780 United States
Key people	Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO)

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

• Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
• College of American Pathologists (CAP) Accreditation 2017
• California Clinical Laboratory License 2016
• Florida Clinical Laboratory License 2016 - 2018
• Pennsylvania Clinical Laboratory Permit 2016-2017
• Maryland Medical Laboratory License 2015-2016

Top 5 Recent Tweets

Date	Author	Comment
October 05, 2022	Robbinsllp	The U.S. Department of Justice is investigating Fulgent Genetics, Inc. $FLGT for violations of the Anti-Kickback St… https://t.co/raG3PtsqgJ
September 30, 2022	BlockLevitonLLP	A class action lawsuit has been filed against Fulgent Genetics, Inc. $FLGT for potential securities law violations.… https://t.co/Dvz9mjwnMN
October 05, 2022	newmediawire	ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Se https://t.co/zn0DFgBX1G https://t.co/g9tzIMGBkg
October 05, 2022	TheTradingBlvd	FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS W… https://t.co/9Cm99EqBqV

Top 5 Lifetime News Headlines

Top Authors

• Archana Sinha
• View all authors

Verification history

• 2,165 days ago


• View all verifications